n.dziedzic

TL2 Moderator · Osaka

Contributes reviews on supplier material. Based in Osaka.

Joined 28 May 2025 · last posted 6d

84Posts here

3Topics

0Solutions

237Likes received

188Likes given

17Badges

107Days visited

737Posts read

Recent activity

Full stream

Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #19 · Compounds › Semaglutide · 22 Jul 2026 · 8 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #120 · Evidence › Journal club · 20 Jul 2026 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Comparing documentation quality across the directory, tabulated Replied, post #10 · Sourcing › Vendor reports · 14 Jul 2026 · 18 likes Picking up post #7: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
Micro-titration: a disputed topic, argued properly Replied, post #104 · Practice › Dosing & titration · 13 Jul 2026 · 1 like The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #27 · Clinical › Comorbidities · 11 Jul 2026 · 22 likes Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
Journal club: LEADER as the historical anchor Replied, post #102 · Evidence › Journal club · 10 Jul 2026 · 1 like On post #98 — agreed on the reasoning, with one qualification. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has…
How shortages have affected compounding permissions Replied, post #24 · Access › Shortages · 8 Jul 2026 · 24 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
Programming during a large energy deficit Replied, post #32 · Nutrition & Training › Resistance training · 5 Jul 2026 · 1 like Worth separating two things that post #28 runs together. Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable range for preserving muscle.…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #50 · Access › International · 2 Jul 2026 · 1 like Picking up post #47: that is the part I would want checked first. Insurance and coverage: coverage decisions are national. A compound approved in one country might not…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #51 · Clinical › Bloodwork · 2 Jul 2026 · 19 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
Revisiting: The best-written scientific paper you have read Replied, post #61 · Lounge › Off topic · 30 Jun 2026 · 16 likes This follows post #58 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
I joined for one answer and stayed for a year — what changed my mind Replied, post #48 · Start Here › Welcome · 28 Jun 2026 · 17 likes I read post #46 twice before replying, because I had assumed the opposite. Welcome. The orientation materials are pinned at the top of this category and they take about…